Innate Pharma SA (NASDAQ:IPHA) currently has 3 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| MORGAN STANLEY | 30 Sep, 2025 | 53,564 | 2,340 | 4.57% | $103,378.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 20,042 | 20,042 | 0.00% | $39,082.00 |
| UBS Group AG | 30 Sep, 2025 | 4,797 | -1,160 | -19.47% | $9,258.00 |
| GAMMA Investing LLC | 30 Sep, 2025 | 2,281 | -1,175 | -34.00% | $4,402.00 |
| RHUMBLINE ADVISERS | 30 Sep, 2025 | 470 | 0 | 0.00% | $916.00 |
| BARCLAYS PLC | 30 Sep, 2025 | 307 | 0 | 0.00% | $593.00 |
| Optiver Holding B.V. | 30 Sep, 2025 | 101 | 0 | 0.00% | $197.00 |
| PRINCIPAL SECURITIES, INC. | 30 Sep, 2025 | 45 | 0 | 0.00% | $87.00 |
| Farther Finance Advisors, LLC | 30 Sep, 2025 | 10 | 10 | 0.00% | $19.00 |